• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
A vision for closing the evidence-practice gap in the management of low-grade prostate cancer.缩小低级别前列腺癌管理中证据与实践差距的愿景。
JNCI Cancer Spectr. 2023 Mar 1;7(2). doi: 10.1093/jncics/pkad028.
2
Low-Grade Prostate Cancer: Time to Stop Calling It Cancer.低级别前列腺癌：是时候不再称其为癌症了。
J Clin Oncol. 2022 Sep 20;40(27):3110-3114. doi: 10.1200/JCO.22.00123. Epub 2022 Apr 18.
3
Newly Proposed Prognostic Grade Group System for Prostate Cancer: Genesis, Utility and its Implications in Clinical Practice.新提出的前列腺癌预后分级组系统：起源、效用及其在临床实践中的意义
Curr Urol Rep. 2016 Nov;17(11):80. doi: 10.1007/s11934-016-0635-x.
4
Brief Overview of Prostate Cancer Statistics, Grading, Diagnosis and Treatment Strategies.前列腺癌统计数据、分级、诊断和治疗策略简介。
Adv Exp Med Biol. 2018;1095:1-14. doi: 10.1007/978-3-319-95693-0_1.
5
Should grade group 1 prostate cancer be reclassified as "non-cancer"? A pathology community perspective.1 级前列腺癌是否应重新归类为“非癌性”？病理学领域的观点。
Urol Oncol. 2023 Feb;41(2):62-64. doi: 10.1016/j.urolonc.2022.09.028. Epub 2022 Nov 23.
6
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.2014年国际泌尿病理学会（ISUP）前列腺癌Gleason分级共识会议：分级模式的定义及新分级系统的建议
Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530.
7
Grading of prostatic adenocarcinoma: current state and prognostic implications.前列腺腺癌的分级：现状及预后意义
Diagn Pathol. 2016 Mar 9;11:25. doi: 10.1186/s13000-016-0478-2.
8
Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.当代前列腺癌的Gleason分级：结合对实施2014年国际泌尿病理学会（ISUP）前列腺癌Gleason分级共识会议实际问题的讨论进行更新
Am J Surg Pathol. 2017 Apr;41(4):e1-e7. doi: 10.1097/PAS.0000000000000820.
9
[Grading of prostate cancer].[前列腺癌的分级]
Pathologe. 2016 Jul;37(4):352-4. doi: 10.1007/s00292-016-0185-5.
10
Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort.1 级前列腺癌的主动监测：来自大型前瞻性队列的长期结果。
Eur Urol. 2020 Jun;77(6):675-682. doi: 10.1016/j.eururo.2019.12.017. Epub 2020 Jan 7.

本文引用的文献

1
Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US.美国低危前列腺癌管理中主动监测应用的时间趋势和变化。
JAMA Netw Open. 2023 Mar 1;6(3):e231439. doi: 10.1001/jamanetworkopen.2023.1439.
2
Prostate cancer grade migration and facility-level treatment trends for grade group 1 disease.前列腺癌分级迁移与分级分组 1 疾病的医疗机构治疗趋势。
JNCI Cancer Spectr. 2023 Mar 1;7(2). doi: 10.1093/jncics/pkad018.
3
Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation.观察管理的局限性前列腺癌患者监测测试的应用
J Urol. 2023 Apr;209(4):710-718. doi: 10.1097/JU.0000000000003159. Epub 2023 Feb 8.
4
Trends in Incidence of Metastatic Prostate Cancer in the US.美国转移性前列腺癌发病率的趋势。
JAMA Netw Open. 2022 Mar 1;5(3):e222246. doi: 10.1001/jamanetworkopen.2022.2246.
5
Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US.美国低危前列腺癌主动监测的区域差异。
JAMA Netw Open. 2020 Dec 1;3(12):e2031349. doi: 10.1001/jamanetworkopen.2020.31349.
6
Elusive Waste: The Fermi Paradox in US Health Care.难以捉摸的浪费：美国医疗保健中的费米悖论
JAMA. 2019 Oct 15;322(15):1458-1459. doi: 10.1001/jama.2019.14610.
7
Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.2005-2015 年退伍军人事务部综合医疗保健系统中低危前列腺癌的保守治疗。
JAMA. 2018 Jun 5;319(21):2231-2233. doi: 10.1001/jama.2018.5616.
8
Leveraging Implementation Science to Improve Cancer Care Delivery and Patient Outcomes.利用实施科学改善癌症护理服务与患者治疗效果。
J Oncol Pract. 2017 Aug;13(8):523-529. doi: 10.1200/JOP.2017.024729. Epub 2017 Jul 10.
9
Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.不同泌尿外科实践中指南一致的主动监测随访的差异。
J Urol. 2017 Mar;197(3 Pt 1):621-626. doi: 10.1016/j.juro.2016.09.071. Epub 2016 Sep 20.
10
Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.1990 - 2013年局限性前列腺癌患者的管理趋势
JAMA. 2015 Jul 7;314(1):80-2. doi: 10.1001/jama.2015.6036.

A vision for closing the evidence-practice gap in the management of low-grade prostate cancer.

作者信息

Leapman Michael S, Loeb Stacy, Cooperberg Matthew R, Catalona William J, Gaylis Franklin D

机构信息

Department of Urology, Yale School of Medicine, New Haven, CT, USA.

Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, New Haven, CT, USA.

出版信息

JNCI Cancer Spectr. 2023 Mar 1;7(2). doi: 10.1093/jncics/pkad028.

DOI:10.1093/jncics/pkad028
PMID:37101361
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10133397/
Abstract
摘要